subscribeSubscribe
NV-387 Broad-Spectrum Antiviral Could Combat Bird Flu H5N1, Says NanoViricides

NV-387 Broad-Spectrum Antiviral Could Combat Bird Flu H5N1, Says NanoViricides
ACCESSWIRE
24 Jun 2024
Share Share
FDA Confirms Paragraph IV Patent Litigation for Baloxavir Marboxil Tablets

FDA Confirms Paragraph IV Patent Litigation for Baloxavir Marboxil Tablets
FDA
13 Jan 2023
Share Share
EU okays Roche`s Xofluza antiviral for children as young as a year old

EU okays Roche`s Xofluza antiviral for children as young as a year old
GLOBENEWSWIRE
13 Jan 2023
Share Share
Roche Gets U.S. Approval for Flu Drug for Children Aged 5 and Over

Roche Gets U.S. Approval for Flu Drug for Children Aged 5 and Over
USNEWS
12 Aug 2022
Share Share
Genentech Announces FDA Approval of Xofluza

Genentech Announces FDA Approval of Xofluza
BUSINESSWIRE
11 Aug 2022
Share Share
What`s the oral antiviral market for endemic COVID-19?

What`s the oral antiviral market for endemic COVID-19?
Angus Liu FIERCEPHARMA
07 Oct 2021
Share Share
Roche gets EU green light for influenza treatment Xofluza

Roche gets EU green light for influenza treatment Xofluza
S. Koltrowitz REUTERS
11 Jan 2021
Share Share
Roche`s Xofluza wins FDA nod to prevent flu but also hits a snag

Roche`s Xofluza wins FDA nod to prevent flu but also hits a snag
Angus Liu FIERCE PHARMA
25 Nov 2020
Share Share
FDA Expands Approval of Influenza Treatment to Post-Exposure Prevention

FDA Expands Approval of Influenza Treatment to Post-Exposure Prevention
FDA
24 Nov 2020
Share Share
Meeting highlights from the Committee for Medicinal Products for Human Use

Meeting highlights from the Committee for Medicinal Products for Human Use
EMA
13 Nov 2020
Share Share